Skip to main content

Table 2 Adverse events during the study period

From: A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease

Adverse event type

No. of patients with event (%)

Gastrointestinal related

 Nausea

6 (17.6%)

 Vomiting

1 (2.9%)

 Diarrhea

1 (2.9%)

 Abdominal pain

2 (5.8%)

 Bloating

2 (5.8%)

Non-gastrointestinal related

 Dizziness

1(2.9%)

 Rash

1 (2.9%)

 Renal cyst complications (infection and/or hemorrhage)

4 (11.7%)

 Lactic acidosis

0 (0%)

 Hypoglycemia

0 (0%)

 Death

0 (0%)